Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2026-01-22 @ 2:54 PM
Study NCT ID:
NCT04711161
Status:
SUSPENDED
Last Update Posted:
2024-01-23
First Post:
2020-12-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Sponsor:
Green3Bio, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ovarian Tumors | View |
Keywords: